Compare RAPP & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | RAPP | KW |
|---|---|---|
| Founded | 2022 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2024 | 2007 |
| Metric | RAPP | KW |
|---|---|---|
| Price | $36.56 | $10.90 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 1 |
| Target Price | ★ $48.50 | $11.00 |
| AVG Volume (30 Days) | 251.7K | ★ 907.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.40% |
| EPS Growth | 24.34 | ★ 50.00 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $62,633,000.00 |
| Revenue This Year | N/A | $81.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 23.94 |
| 52 Week Low | $7.73 | $5.98 |
| 52 Week High | $42.27 | $10.99 |
| Indicator | RAPP | KW |
|---|---|---|
| Relative Strength Index (RSI) | 74.25 | 57.47 |
| Support Level | $25.48 | $10.82 |
| Resistance Level | $42.27 | $10.97 |
| Average True Range (ATR) | 1.93 | 0.05 |
| MACD | 0.60 | -0.02 |
| Stochastic Oscillator | 97.74 | 46.88 |
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.